https://www.taxtmi.com/caselaws?id=214906 Waste material arising during manufacture of bulk drugs and cleared at nil duty was not treated as requiring reversal or payment of 8% or 10% of value under Rule 6 of the Cenvat Credit Rules, 2002/2004. The record showed that Cenvat credit had been taken on inputs used for manufacture of the final product, but the exempted clearance of waste was considered covered by binding precedent and outside the disputed reversal demand. On that basis, the demand, interest and penalty were held unsustainable. en-us Thu, 07 Jun 2012 00:00:00 +0530 Fri, 20 Jul 2012 11:48:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=214906 Waste material arising during manufacture of bulk drugs and cleared at nil duty was not treated as requiring reversal or payment of 8% or 10% of value under Rule 6 of the Cenvat Credit Rules, 2002/2004. The record showed that Cenvat credit had been taken on inputs used for manufacture of the final product, but the exempted clearance of waste was considered covered by binding precedent and outside the disputed reversal demand. On that basis, the demand, interest and penalty were held unsustainable. Case-Laws Central Excise Thu, 07 Jun 2012 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=214906